Lack of association between methylenetetrahydrofolate reductase genetic polymorphisms and postmenopausal breast cancer risk

Molecular Medicine Reports

Volumn 4, Issue 1, 2011, Pages 175-179

  Cerne, Jasmina Ziva ^a   Stegel, Vida ^b   Gersak, Ksenija ^a   Novakovic, Srdjan ^b  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b INSTITUTE OF ONCOLOGY   (Slovenia)

Author keywords

Breast cancer; Folate; Methylenetetrahydrofolate reductase

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ADULT; AGED; ALLELE; ARTICLE; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNICITY; FEMALE; GENE INTERACTION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HORMONE SUBSTITUTION; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; POSTMENOPAUSE; QUESTIONNAIRE; TREATMENT DURATION;

AGED; BREAST; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HORMONE REPLACEMENT THERAPY; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, GENETIC; POSTMENOPAUSE; RISK FACTORS;

EID: 78651380977     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2010.406     Document Type: Article

References (17)

1. Kim YI: Folate and carcinogenesis: evidence, mechanisms, and implications. J Nutr Biochem 10: 66-88, 1999.
2. Duthie SJ: Folate and cancer: how DNA damage, repair and methylation impact on colon carcinogenesis. J Inherit Metab Dis: June, 2010 (E-pub ahead of print).
3. Kim YI: Folate and colorectal cancer: an evidence-based critical review. Mol Nutr Food Res 51: 267-292, 2007 (Pubitemid 47083662)
4. Suzuki T, Matsuo K, Hirose K, et al: One-carbon metabolism-related gene polymorphisms and risk of breast cancer. Carcinogenesis 29: 356-362, 2008. (Pubitemid 351359675)
5. Frosst P, Blom HJ, Milos R, et al: A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genetics 10: 111-113, 1995.
6. Weisberg I, Tran P, Christensen B, Sibani R and Rozen R: A second polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 64: 169-172, 1998. (Pubitemid 28453294)
7. Van der Put NM, Gabreels F, Stevens EM, et al: A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Med Genet 62: 1044-1051, 1998.
8. Maruti SS, Ulrich CM, Jupe ER and White E: MTHFR C677T and postmenopausal breast cancer risk by intakes of one-carbon metabolism nutrients: a nested case-control study. Breast Cancer Res 11: R91, 2009.
9. Kotsopoulos J, Zhang WW, Zhang S, et al: Polymorphisms in folate metabolizing enzymes and transport proteins and the risk of breast cancer. Breast Cancer Res Treat 112: 585-593, 2008.
10. Ericson U, Sonestedt E, Ivarsson MI, Gullberg B, Carlson J, Olsson H and Wirfält E: Folate intake, methylenetetrahydrofolate reductase polymorphisms, and breast cancer risk in women from the Malmö Diet and Cancer cohort. Cancer Epidemiol Biomarkers Prev 18: 1101-1110, 2009.
11. Zhang J, Qiu LX, Wang ZH, et al: MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls. Breast Cancer Res Treat 123: 549-555, 2010.
12. Qi X, Ma X, Yang X, et al: Methylenetetrahydrofolate reductase polymorphism and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls. Breast Cancer Res Treat 123: 499-506, 2010.
13. Choi SW and Mason JB: Folate status: effects on pathways of colorectal carcinogenesis. J Nutr 132: 2413-2418, 2002.
14. Le Marchand L, Haiman CA, Wilkens LR, Kolonel LN and Henderson BE: MTHFR polymorphisms, diet, HRT and breast cancer risk: the Multiethnic Cohort Study Cancer Epidemiol Biomarkers Prev 13: 2071-2077, 2004
15. Somekawa Y, Kobayashi K, Tomura S, Aso T and Hamaguchi H: Effects of hormone replacement therapy and methylenetetrahydrofolate reductase polymorphism on plasma folate and homocysteine levels in postmenopausal Japanese women. Fertil Steril 77: 481-486, 2002. (Pubitemid 34177201)
16. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer: Collaborative Group on Hormonal Factors in Breast Cancer. Lancet 350: 1047-1059, 1997 (Pubitemid 27437855)
17. Finley C, Gregg EV, Solomon LJ and Gay E: Disparities in hormone replacement therapy use by socioeconomic status in a primary care population. J Community Health 26: 39-50, 2001. (Pubitemid 33638551)